Carisma Therapeutics' Debt Round

Carisma Therapeutics raised a round of funding on June 12, 2017.

Carisma Therapeutics, formerly CARMA Therapeutics, is a developer of CAR macrophages, a disruptive approach to immunotherapy. Its technology leverages advances in macrophage biology, chimeric antigen …

Articles about Carisma Therapeutics' Debt Round: